Literature DB >> 12006746

Is there a gender difference in a factorial structure of the positive and negative syndrome scale? A test by structural equation modeling.

Naoki Hayashi1, Yoshito Igarashi, Mitsuru Yamashina, Kiyoko Suda.   

Abstract

By means of the multisample structured means strategy, we examined gender differences in a five-factorial structure model of Positive and Negative Syndrome Scale (PANSS) ratings of 308 patients of both sexes with DSM-IV schizophrenia with comparable age at investigation and overall symptomatic severity across sex. The test indicated that the factors and component symptoms were common across sex, whereas the factor loadings might be different. However, the model that incorporated the difference in the factor loadings did not improve model fit indices. Therefore, it is concluded that this investigation elicited only minimal gender differences, and on the whole confirmed the PANSS five-factor structure for both sexes. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12006746     DOI: 10.1159/000056213

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  9 in total

Review 1.  The structure of negative symptoms within schizophrenia: implications for assessment.

Authors:  Jack J Blanchard; Alex S Cohen
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

2.  Sparse factors for the positive and negative syndrome scale: which symptoms and stage of illness?

Authors:  Ariana Anderson; Marsha Wilcox; Adam Savitz; Hearee Chung; Qingqin Li; Giacomo Salvadore; Dai Wang; Isaac Nuamah; Steven P Riese; Robert M Bilder
Journal:  Psychiatry Res       Date:  2015-01-06       Impact factor: 3.222

Review 3.  Are Shorter Versions of the Positive and Negative Syndrome Scale (PANSS) Doable? A Critical Review.

Authors:  Jean-Pierre Lindenmayer
Journal:  Innov Clin Neurosci       Date:  2017-12-01

4.  Measuring Voluntary Control Over Hallucinations: The Yale Control Over Perceptual Experiences (COPE) Scales.

Authors:  Catalina Mourgues; Allison Hammer; Victoria Fisher; Eren Kafadar; Brittany Quagan; Claire Bien; Hale Jaeger; Rigi Thomas; Ely Sibarium; Alyson M Negreira; Elif Sarisik; Vasishta Polisetty; Hatice Nur Eken; Ayyub Imtiaz; Halsey Niles; Andrew D Sheldon; Albert R Powers
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

5.  Lack of Gender-Related Differences in Childhood-Onset Schizophrenia.

Authors:  Anna E Ordóñez; Frances F Loeb; Xueping Zhou; Lorie Shora; Rebecca A Berman; Diane D Broadnax; Peter Gochman; Siyuan Liu; Judith L Rapoport
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2016-07-01       Impact factor: 8.829

Review 6.  Gender differences in individuals at high-risk of psychosis: a comprehensive literature review.

Authors:  Ana Barajas; Susana Ochoa; Jordi E Obiols; Lluís Lalucat-Jo
Journal:  ScientificWorldJournal       Date:  2015-01-01

7.  Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.

Authors:  Susana Ochoa; Judith Usall; Jesús Cobo; Xavier Labad; Jayashri Kulkarni
Journal:  Schizophr Res Treatment       Date:  2012-04-08

8.  Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study.

Authors:  Bernardo Carpiniello; Federica Pinna; Massimo Tusconi; Enrico Zaccheddu; Francesca Fatteri
Journal:  Schizophr Res Treatment       Date:  2012-01-16

9.  Staging of Schizophrenia With the Use of PANSS: An International Multi-Center Study.

Authors:  Konstantinos N Fountoulakis; Elena Dragioti; Antonis T Theofilidis; Tobias Wikilund; Xenofon Atmatzidis; Ioannis Nimatoudis; Erik Thys; Martien Wampers; Luchezar Hranov; Trayana Hristova; Daniil Aptalidis; Roumen Milev; Felicia Iftene; Filip Spaniel; Pavel Knytl; Petra Furstova; Tiina From; Henry Karlsson; Maija Walta; Raimo K R Salokangas; Jean-Michel Azorin; Justine Bouniard; Julie Montant; Georg Juckel; Ida S Haussleiter; Athanasios Douzenis; Ioannis Michopoulos; Panagiotis Ferentinos; Nikolaos Smyrnis; Leonidas Mantonakis; Zsófia Nemes; Xenia Gonda; Dora Vajda; Anita Juhasz; Amresh Shrivastava; John Waddington; Maurizio Pompili; Anna Comparelli; Valentina Corigliano; Elmars Rancans; Alvydas Navickas; Jan Hilbig; Laurynas Bukelskis; Lidija Injac Stevovic; Sanja Vodopic; Oluyomi Esan; Oluremi Oladele; Christopher Osunbote; Janusz Κ Rybakowski; Pawel Wojciak; Klaudia Domowicz; Maria Luisa Figueira; Ludgero Linhares; Joana Crawford; Anca-Livia Panfil; Daria Smirnova; Olga Izmailova; Dusica Lecic-Tosevski; Henk Temmingh; Fleur Howells; Julio Bobes; Maria Paz Garcia-Portilla; Leticia García-Alvarez; Gamze Erzin; Hasan Karadağ; Avinash De Sousa; Anuja Bendre; Cyril Hoschl; Cristina Bredicean; Ion Papava; Olivera Vukovic; Bojana Pejuskovic; Vincent Russell; Loukas Athanasiadis; Anastasia Konsta; Dan Stein; Michael Berk; Olivia Dean; Rajiv Tandon; Siegfried Kasper; Marc De Hert
Journal:  Int J Neuropsychopharmacol       Date:  2019-11-01       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.